Limnopharma Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Limnopharma General Information

Description

Developer of pharmaceutical research drugs designed to create new treatments for degenerative retinal disorders. The company offers small-molecule drug candidates derived from natural compounds with neuroprotective and anti-inflammatory properties, enabling patients with retinal diseases and ophthalmology specialists to access non-invasive therapeutic options that aim to preserve vision and improve long-term eye health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Queen Mary Building, Bailén-Motril Highway
  • Bailén-Motril Highway, South/North, Parc 102
  • 18210 Granada
  • Spain
+34 626
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Queen Mary Building, Bailén-Motril Highway
  • Bailén-Motril Highway, South/North, Parc 102
  • 18210 Granada
  • Spain
+34 626

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Limnopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Feb-2025 Completed Generating Revenue
2. Grant 01-Jan-2021 Completed Clinical Trials - General
1. Early Stage VC 23-May-2019 $140K $140K Completed Clinical Trials - General
To view Limnopharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Limnopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceutical research drugs designed to create new treatments for degenerative retinal disorders. The com
Drug Discovery
Granada, Spain

London, United Kingdom
 

San Sebastián, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Limnopharma Competitors (6)

One of Limnopharma’s 6 competitors is Mito.Tech, a Venture Capital-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mito.Tech Venture Capital-Backed London, United Kingdom
Miramoon Pharma Accelerator/Incubator Backed San Sebastián, Spain
SparingVision Venture Capital-Backed Paris, France
Alkeus Pharmaceuticals Formerly VC-backed Cambridge, MA
InflammX Venture Capital-Backed Tampa, FL
To view Limnopharma’s complete competitors history, request access »

Limnopharma Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medex Partners Venture Capital Minority
Fondation de l'Avenir Government
Genesis Ventures Venture Capital Minority
Covirán Corporation Minority
Genesis Biomed Venture Capital Minority
To view Limnopharma’s complete investors history, request access »

Limnopharma FAQs

  • When was Limnopharma founded?

    Limnopharma was founded in 2019.

  • Where is Limnopharma headquartered?

    Limnopharma is headquartered in Granada, Spain.

  • What industry is Limnopharma in?

    Limnopharma’s primary industry is Drug Discovery.

  • Is Limnopharma a private or public company?

    Limnopharma is a Private company.

  • What is Limnopharma’s current revenue?

    The current revenue for Limnopharma is .

  • How much funding has Limnopharma raised over time?

    Limnopharma has raised $140K.

  • Who are Limnopharma’s investors?

    Medex Partners, Fondation de l'Avenir, Genesis Ventures, Covirán, and Genesis Biomed have invested in Limnopharma.

  • Who are Limnopharma’s competitors?

    Mito.Tech, Miramoon Pharma, SparingVision, Alkeus Pharmaceuticals, and InflammX are some of the 6 competitors of Limnopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process